Myxoma virus

From WikiMD's WELLNESSPEDIA

Myxoma virus is a virus that belongs to the family Poxviridae and the genus Leporipoxvirus. It is known for causing myxomatosis in rabbits, a disease that can be fatal. The virus is spread through direct contact, as well as by vectors such as fleas and mosquitoes.

History[edit]

The Myxoma virus was first identified in the 1890s in Uruguay. It was later used in Australia and Europe in the 1950s as a biological control agent to reduce rabbit populations, which had become pests in these areas. However, the use of the virus led to the evolution of both the virus and the rabbit species, with the virus becoming less virulent and the rabbits developing resistance.

Structure[edit]

The Myxoma virus is a large, double-stranded DNA virus. It has a complex structure, with a central core containing the DNA, surrounded by layers of proteins and lipids. The virus has a number of genes that help it evade the host's immune response.

Pathogenesis[edit]

The Myxoma virus causes myxomatosis in rabbits, a disease characterized by skin tumors, fever, and often death. The virus enters the body through the skin, often via a bite from a vector. It then replicates in the local tissue before spreading to the lymph nodes and the rest of the body.

Treatment and control[edit]

There is no specific treatment for myxomatosis. Control measures include vaccination and the control of vectors. In areas where the virus is used for biological control of rabbit populations, the virus is often deliberately released.

See also[edit]

References[edit]


Myxoma_virus[edit]

Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.